AbbVie Inc. (ABBV): debt financing — AbbVie amends revolver: commitments raised to $5.0B, maturity extended to 2028

AbbVie Inc.

Revolving credit facility commitments increased from $4.0B to $5.0B.
Maturity date extended from August 27, 2024 to March 28, 2028.
Facility remains unsecured; JPMorgan Chase continues as administrative agent.
Second Amended and Restated Revolving Credit Agreement dated March 28, 2023.

item 1.01 item 2.03 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

AbbVie Inc. amended revolving credit of $5.0 billion with JPMorgan Chase Bank, N.A. maturing March 28, 2028.

Instrument: revolving credit
Principal: $5.0 billion
Counterparty: JPMorgan Chase Bank, N.A.
Maturity: March 28, 2028
Event: amendment

Exact text from the filing

(i) increases the unsecured revolving credit facility commitments from $4.0 billion to $5.0 billion and (ii) extends the maturity date of the facility from August 27, 2024 to March 28, 2028.

View on SEC.gov

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

AbbVie Inc. entered into Second Amended and Restated Revolving Credit Agreement with JPMorgan Chase Bank, N.A. valued at $5.0 billion (effective 2023-03-28).

Action: entry
Agreement: credit facility
Counterparty: JPMorgan Chase Bank, N.A.
Value: $5.0 billion
Effective: 2023-03-28

Exact text from the filing

On March 28, 2023 (the “Effective Date”), AbbVie Inc. (“AbbVie”) entered into an amended and restated revolving credit agreement (the “Second Amended and Restated Revolving Credit Agreement”) among AbbVie, as borrower, the lenders and other parties party thereto and JPMorgan Chase Bank, N.A., as administrative agent

View on SEC.gov

222 debt financings filed in the last 30 days. Browse all debt financings →

AbbVie Inc. filing history →

Source: SEC EDGAR

accession 0001104659-23-037749

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.